StageZero Life Sciences Ltd.
SZLS
Rang in Aktien
#36089
StageZero Life Sciences Ltd. is a vertically integrated healthcare enterprise... StageZero Life Sciences Ltd. is a vertically integrated healthcare enterprise specializing in the development and market release of advanced molecular diagnostic tests. These innovative solutions are designed for the proactive detection of diseases and individualized health management, with a particular emphasis on oncology-related conditions across North America. Central to its operations is the proprietary Sentinel Principle platform, which enables the identification of novel biomarkers directly from whole blood samples. Its flagship product, Aristotle, exemplifies this innovation; it's a comprehensive multi-cancer panel that simultaneously screens for numerous cancers from a single blood draw, boasting impressive sensitivity and specificity for each identified malignancy. Beyond Aristotle, the company's portfolio includes ColonSentry, a blood-based test gauging colorectal cancer risk; COVID-19 PCR testing and general blood analysis services; the Prostate Health Index for prostate cancer screening; and BreastSentry, designed to evaluate a woman's susceptibility to breast cancer. Established in 1998, StageZero Life Sciences Ltd. maintains its headquarters in Richmond Hill, Canada.
Aktienkurs
$0.02770208
Zuletzt synchronisiert: 2025-03-10
Marktkapitalisierung
$2.92M
Veränderung (1 Tag)
-0.46%
Veränderung (1 Jahr)
443.18%
Land
CA
Handel StageZero Life Sciences Ltd. (SZLS)
Kategorie
Healthcare
Marktkapitalisierung von StageZero Life Sciences Ltd.(SZLS)
Marktkapitalisierung: $2.92M
Mit Stand October 2026 hat StageZero Life Sciences Ltd. eine Marktkapitalisierung von $2.92M. Das macht StageZero Life Sciences Ltd. laut unseren Daten zum 36089th wertvollsten Unternehmen der Welt nach Marktkapitalisierung. Die Marktkapitalisierung ist der Gesamtmarktwert aller ausstehenden Aktien eines börsennotierten Unternehmens und wird häufig verwendet, um den Unternehmenswert zu bestimmen.
Marktkapitalisierung von StageZero Life Sciences Ltd. von 2009 bis 2026
SZLS im Vergleich zu den Top 5 der beliebtesten stocks
| Preis für SZLS | Vermögenswert B | Marktkapitalisierung von B | Ergebnisse | |
|---|---|---|---|---|
$41,827.20
$123.53K
|
$5.167T | +4,182,720,306.69% | ||
|
$40,594.65
$123.53K
|
$5.015T | +4,059,465,112.29% | ||
|
$33,257.53
$123.53K
|
$4.108T | +3,325,752,716.77% | ||
|
$31,585.92
$123.53K
|
$3.902T | +3,158,592,145.39% | ||
|
$21,771.15
$123.53K
|
$2.689T | +2,177,115,360.65% |
